Dr Jason Szu-chieh Ho, MD - Medicare Hematology/oncology in Los Angeles, CA

Dr Jason Szu-chieh Ho, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Los Angeles, California. He went to University Of Illinois College Of Med (chi/peor/rock/chm-urb) and graduated in 2001 and has 23 years of diverse experience with area of expertise as Hematology/oncology. He is a member of the group practice Los Angeles Hematology-oncology Medical Group and his current practice location is 1245 Wilshire Blvd, Suite 303, Los Angeles, California. You can reach out to his office (for appointments etc.) via phone at (213) 977-1214.

Dr Jason Szu-chieh Ho is licensed to practice in California (license number A81221) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1174735658.

Contact Information

Dr Jason Szu-chieh Ho, MD
1245 Wilshire Blvd, Suite 303,
Los Angeles, CA 90017-4810
(213) 977-1214
(213) 482-8868



Physician's Profile

Full NameDr Jason Szu-chieh Ho
GenderMale
SpecialityHematology/oncology
Experience23 Years
Location1245 Wilshire Blvd, Los Angeles, California
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Jason Szu-chieh Ho attended and graduated from University Of Illinois College Of Med (chi/peor/rock/chm-urb) in 2001
  NPI Data:
  • NPI Number: 1174735658
  • Provider Enumeration Date: 05/04/2007
  • Last Update Date: 09/16/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 2365515897
  • Enrollment ID: I20080716000882

Medical Identifiers

Medical identifiers for Dr Jason Szu-chieh Ho such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1174735658NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RH0003XInternal Medicine - Hematology & Oncology A81221 (California)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Glendale Adventist Medical CenterGlendale, CAHospital
Good Samaritan HospitalLos angeles, CAHospital
Hollywood Presbyterian Medical CenterLos angeles, CAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Los Angeles Hematology-oncology Medical Group660881959423

News Archive

Parents of kids with autism spectrum disorders more likely to split: Study

A new study has found that couples who have a child with an autism spectrum disorder (ASD) have an 80% risk of getting divorce. The Adolescents and Adults With Autism study involved 391 families with autistic children and compared them with other families whose children were developing normally. The families were matched based on the age, sex and birth order of the child with an ASD, as well as the age, ethnicity and education of the mother.

House members launch first-ever bipartisan Congressional HIV/AIDS Caucus

Democratic and Republican House members at a press briefing on Thursday formally introduced the first-ever bipartisan Congressional HIV/AIDS Caucus, along with its funding proposals, the Washington Independent reports.

Researchers identify superior blood-based biomarker for assessing sports-related concussions

A high-sensitive blood test can aid concussed hockey players when it might be safe to return to play. In a study published by the journal Neurology, researchers at Sahlgrenska Academy, Sweden, has identified a superior blood-based biomarker for assessing subtle brain injury.

Risk of genetic seizure disorder: new scoring system

A Cleveland Clinic-led initiative has come up with a new risk scoring system for epileptic or seizure disorders of genetic origin. The researchers summed up the risks for a very large number of genes weakly implicated in some common forms of epilepsy, to create a polygenic risk score.

Innovus Pharma announces launch of AllerVarx for relieving nasal, ocular symptoms in allergic patients

Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men's and women's health and respiratory diseases, today announced the launch of AllerVarx in the U.S.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Jason Szu-chieh Ho allows following entities to bill medicare on his behalf.
Entity NameLos Angeles Hematology-oncology Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1457409674
PECOS PAC ID: 6608819594
Enrollment ID: O20050601001068

News Archive

Parents of kids with autism spectrum disorders more likely to split: Study

A new study has found that couples who have a child with an autism spectrum disorder (ASD) have an 80% risk of getting divorce. The Adolescents and Adults With Autism study involved 391 families with autistic children and compared them with other families whose children were developing normally. The families were matched based on the age, sex and birth order of the child with an ASD, as well as the age, ethnicity and education of the mother.

House members launch first-ever bipartisan Congressional HIV/AIDS Caucus

Democratic and Republican House members at a press briefing on Thursday formally introduced the first-ever bipartisan Congressional HIV/AIDS Caucus, along with its funding proposals, the Washington Independent reports.

Researchers identify superior blood-based biomarker for assessing sports-related concussions

A high-sensitive blood test can aid concussed hockey players when it might be safe to return to play. In a study published by the journal Neurology, researchers at Sahlgrenska Academy, Sweden, has identified a superior blood-based biomarker for assessing subtle brain injury.

Risk of genetic seizure disorder: new scoring system

A Cleveland Clinic-led initiative has come up with a new risk scoring system for epileptic or seizure disorders of genetic origin. The researchers summed up the risks for a very large number of genes weakly implicated in some common forms of epilepsy, to create a polygenic risk score.

Innovus Pharma announces launch of AllerVarx for relieving nasal, ocular symptoms in allergic patients

Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men's and women's health and respiratory diseases, today announced the launch of AllerVarx in the U.S.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Jason Szu-chieh Ho is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Jason Szu-chieh Ho, MD
541 W Colorado St Ste 205,
Glendale, CA 91204-3640

Ph: (323) 254-0046
Dr Jason Szu-chieh Ho, MD
1245 Wilshire Blvd, Suite 303,
Los Angeles, CA 90017-4810

Ph: (213) 977-1214

News Archive

Parents of kids with autism spectrum disorders more likely to split: Study

A new study has found that couples who have a child with an autism spectrum disorder (ASD) have an 80% risk of getting divorce. The Adolescents and Adults With Autism study involved 391 families with autistic children and compared them with other families whose children were developing normally. The families were matched based on the age, sex and birth order of the child with an ASD, as well as the age, ethnicity and education of the mother.

House members launch first-ever bipartisan Congressional HIV/AIDS Caucus

Democratic and Republican House members at a press briefing on Thursday formally introduced the first-ever bipartisan Congressional HIV/AIDS Caucus, along with its funding proposals, the Washington Independent reports.

Researchers identify superior blood-based biomarker for assessing sports-related concussions

A high-sensitive blood test can aid concussed hockey players when it might be safe to return to play. In a study published by the journal Neurology, researchers at Sahlgrenska Academy, Sweden, has identified a superior blood-based biomarker for assessing subtle brain injury.

Risk of genetic seizure disorder: new scoring system

A Cleveland Clinic-led initiative has come up with a new risk scoring system for epileptic or seizure disorders of genetic origin. The researchers summed up the risks for a very large number of genes weakly implicated in some common forms of epilepsy, to create a polygenic risk score.

Innovus Pharma announces launch of AllerVarx for relieving nasal, ocular symptoms in allergic patients

Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men's and women's health and respiratory diseases, today announced the launch of AllerVarx in the U.S.

Read more News

› Verified 3 days ago


Internal Medicine Doctors in Los Angeles, CA

Dr. Linda Fong, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034
Phone: 323-857-3290    
Dr. Robert Peter Gale,
Hematology & Oncology
Medicare: Medicare Enrolled
Practice Location: 11693 San Vicente Blvd, Suite 335, Los Angeles, CA 90049
Phone: 310-442-9010    
Dr. Tarek Alasil, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 8616 La Tijera Blvd Ste 404, Los Angeles, CA 90045
Phone: 310-673-2020    Fax: 310-469-5290
David Michael Tellalian, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 8635 W 3rd St Ste 465w, Los Angeles, CA 90048
Phone: 310-358-2300    Fax: 310-358-2308
Dr. Jan B King, M.D., M.P.H.
Hematology & Oncology
Medicare: Not Enrolled in Medicare
Practice Location: 11833 Wilmington Ave Fl 2, Los Angeles, CA 90059
Phone: 323-568-8701    
Dr. Caroline Hwang, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1520 San Pablo St, Suite 1000, Los Angeles, CA 90033
Phone: 323-442-5100    
Dr. Jennifer A Fulcher, M.D., PH.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 10833 Le Conte Ave, Chs 37-121, Los Angeles, CA 90095
Phone: 310-825-7225    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.